MEGAN WALKER: Open Payments
NPI 1013513613 · ABINGDON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,000 in 86 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $1,256 · 2025 $2,000
Food & beverage: $1,913Education: $87
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 18 | $542 |
| Janssen Biotech, Inc. | 21 | $418 |
| Regeneron Healthcare Solutions, Inc. | 14 | $316 |
| PFIZER INC. | 4 | $186 |
| Organon LLC | 6 | $79 |
| Novartis Pharmaceuticals Corporation | 4 | $66 |
| Galderma Laboratories, L.P. | 3 | $56 |
| LEO Pharma Inc. | 2 | $52 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $47 |
| Almirall LLC | 2 | $44 |
Products named: Bimzelx, TREMFYA, DUPIXENT, LITFULO, CIBINQO, COSENTYX, NEMLUVIO, Klisyri.
Industry payments across MD — which companies pay providers there.
